Jinyu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinyu Bio-Technology Co Ltd with three other
companies in this sector in CHINA :
Vcanbio Cell & Gene Engineering Corp Ltd
sales of 1.32 billion Chinese Renmimbi [US$206.29 million]
of which 61%
Anhui Anke Biotechnology (Group) Company., Limited
(1.70 billion Chinese Renmimbi [US$266.51 million]
of which 53%
was Biological Products), and
Tianjin Ringpu Bio-Technology Co Ltd
(2.00 billion Chinese Renmimbi [US$313.34 million]
of which 56%
was Veterinary Biological Products).
During the second
quarter of 2021, sales at Jinyu Bio-Technology Co Ltd totalled
313.03 million Chinese Renmimbi.
an increase of 22.1%
from the 256.29 million Chinese Renmimbi in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 840.43 million Chinese Renmimbi, which is
than through the first two quarters of 2020.
During the previous 6 quarters, sales at Jinyu Bio-Technology Co Ltd have increased compared with the same quarter in the previous year.
During the year ended December of 2020, sales at
Jinyu Bio-Technology Co Ltd were 1.58 billion Chinese Renmimbi (US$247.79 million).
increase of 40.4%
versus 2019, when the company's sales were 1.13 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2018, when Jinyu Bio-Technology Co Ltd
reported sales of 1.90 billion Chinese Renmimbi.
Sales of Other Business saw an increase
that was more than double the company's growth rate: sales were up
105.5% in 2020, from
7.10 million Chinese Renmimbi to 14.59 million Chinese Renmimbi.